
Skin Cancer

Shorts






All News

Day 1 of Maui Derm NP+PA Fall 2026 highlighted emerging therapies, cutaneous oncology, challenging dermatitis cases, and procedural pearls.

Faculty from the Cutaneous Oncology Workshop answer practical questions spanning skin cancer prevention, diagnosis, treatment, and follow-up.

The inaugural workshop explored skin cancer care from prevention and diagnosis through systemic therapy, radiation, and multidisciplinary management.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

The final session of the Cutaneous Oncology Workshop explored advances in systemic therapy, management of immunotherapy-related skin reactions, and the role of radiation.

At the Dermatology Times NP/PA Cutaneous Oncology Workshop in Tampa, Florida, Amit Om, MD, outlined why field-directed therapy is increasingly favored over lesion-directed treatment for actinic keratosis.

Faculty at the Dermatology Times Cutaneous Oncology Workshop addressed real-world questions on mole mapping, biopsy decisions, oral photoprotection, and actinic keratosis treatment.

Chantel Hillestad, RN, MSN, DCNP, FNP-C, shares 10 practical tips for conducting thorough full-body skin examinations.

A meta-analysis found significantly lower SCC risk in patients with vitiligo, offering useful context for skin cancer and phototherapy counseling.

Test your knowledge of Tudriqev’s accelerated approval, clinical activity, administration, and ongoing confirmatory research.

Chantel K. Hillestad, MSN, DCNP, FNP-C, discusses recurrent MCC, treatment access, and care coordination for patients in rural communities.

An MCC case illustrates how travel distance and limited oncology access can influence treatment decisions and adherence in rural patients.


Patient education and partner involvement significantly enhance melanoma detection, especially in underserved and skin-of-color populations, improving survival outcomes.

Maui Derm NP+PA Fall 2025 conference showcases cutting-edge insights in dermatology, featuring expert discussions on skin cancer, atopic dermatitis, and rare dermatoses.

CD19 CAR T-cell therapy may modulate immune dysregulation in underlying diseases such as psoriasis.

Bree Vanleeuwen, PA-C, and Jim Sutton, PA-C, discussed the Skin Cancer Awareness project—a unique initiative to train cosmetologists and hairdressers to recognize suspicious skin lesions and refer clients for dermatologic evaluation.

Renata Block, MMS, PA-C, interviews dermatology clinicians and the Melanoma Research Foundation CEO at the Chicago SPF Fest.

Andrew Baker, MBA, MPAS, PA-C, discusses his role in skin cancer detection and advice for PAs interested in skin surgeries and Mohs closures.

The needs assessment surveyed patients’ stage of treatment, radiation-induced dermatologic adverse effects, and over-the-counter products and home remedies that were used.

Hasbargen presented Mohs surgery pearls on closure types and pattern recognition at the 2024 Diversity in Dermatology meeting.

A team of dermatology physician assistants recently reviewed the current and future potential of genomic testing in the realm of dermatology.

DecisionDx-Melanoma significantly influences treatment plans for melanoma patients, as reported by 82.4% of surveyed nurse practitioners and physician assistants.

With artificial intelligence taking front and center in many aspects of our lives, will it be more prevalent in the dermatology practice than it is now?

Renata Block, MMS, PA-C, spearheaded a skin cancer screening event for veterans in her hometown.

Leading clinicians discuss sun protection best practices based on weather, climate, and travel needs.

Leading clinicians discuss sun protection and special issues in photosensitivity.

Leading clinicians debunk 5 of the most common sunscreen myths.

Discussing photoprotection with patients is crucial as “Melanoma May" kicks off this month.
















